Stocks · Health care · Pharmaceutical Preparations

TALPHERA, INC.

TLPH Clue Score41
United States Fiscal year ends December CIK 0001427925 Results filed 12 Aug 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Raffi Asadorian
2 Dec 2024
Chief Financial Officer
Sell
155
$0.77
$118.89
Pamela P Palmer
25 Aug 2023
Chief Medical Officer
Sell
7,442
$1.09
$8.10K
Pamela P Palmer
24 Aug 2023
Chief Medical Officer
Sell
9,514
$1.17
$11.13K
Badri N Dasu
15 Oct 2018
Chief Engineering Officer
Sell
28,351
$5.00
$141.76K
Lawrence G Hamel
15 Oct 2018
Chief Development Officer
Sell indirect
5,216
$5.00
$26.08K
Lawrence G Hamel
24 Sep 2018
Chief Development Officer
Sell indirect
6,953
$4.50
$31.29K
Lawrence G Hamel
2 Oct 2017
Chief Development Officer
Sell indirect
10,161
$5.29
$53.75K
Lawrence G Hamel
25 Sep 2017
Chief Development Officer
Sell indirect
13,827
—
no price
Perceptive Advisors LLC
19 Jun 2017
10% owner
Sell indirect
875,000
$2.40
$2.10M

What was left out

Form 4 filings counted 235
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 7
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 9
Transactions with no price 1
Shares from compensation/vesting 13,220,566
Sales filed before the plan box existed 6
History held since 18 Feb 2011